🟡An Act relating to certain health care services contract arrangements entered into by insurers and health care providers.
HB 2254
🟡 HB 2254: Expands PPO and EPO capitation contracts in Texas healthcare
What it says it does:
HB 2254 allows PPO and EPO health insurance plans to contract directly with primary care doctors using “value-based” and capitation payment models, where doctors are paid a fixed amount per patient instead of per service. It says this will promote affordability and flexibility in how care is delivered.
What it actually changes:
Before this bill, only HMOs could use capitation. HB 2254 gives that same authority to PPO and EPO plans, removing a key regulatory barrier. It also says doctors who enter these arrangements are not considered to be “engaging in the business of insurance,” which shields these contracts from deeper state review. The Texas Department of Insurance only handles complaints after the fact, not before contracts take effect.
Who is pushing for it:
Support came from the Texas Association of Health Plans, Blue Cross Blue Shield of Texas, the Texas Association of Business, AARP Texas, NABIP-TX, and the Texas Medical Association. Each backed the idea of expanding flexible contracts and cutting costs.
Who benefits:
Large insurers gain new control over cost and network design. Big physician groups with data and management capacity gain leverage to negotiate risk-based deals. Employer coalitions get more predictable premiums.
Who gets left out or exposed:
Independent and rural physicians face tougher pressure to join capitation contracts they can’t easily manage. Patients with complex or chronic conditions could face subtle barriers to care if performance metrics focus more on cost savings than outcomes. The public loses transparency since these contracts are private and not publicly reviewed.
Why this matters long term:
HB 2254 reshapes how primary care is financed by moving decisions about value and cost into private contracts that regulators rarely see. Once these models are normalized, they can spread to other specialties or services, making it harder to monitor how cost control affects patient access.
What to watch next:
Watch whether insurers push to expand capitation beyond primary care. Track whether smaller doctors drop from networks. See if TDI ever adds proactive review or remains a complaint-only referee.
Bottom line:
HB 2254 sells flexibility and value-based care, but it quietly shifts decision-making power from public oversight to private insurers. Without stronger safeguards, cost control could come before patient care.
#HB2254 #TexasPolicy #HealthCare #InsuranceContracts #WatchTheRules